StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) stock

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$146.58+2.23 (+1.54%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Palvella Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Palvella Therapeutics's pe ratio was 0.7× on Jan 31, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20250.7×+0.1
2024Dec 31, 20240.6×–

More Palvella Therapeutics figures

See a number that looks wrong?